Zealand increases its share capital as a consequence of exercise of employee warrants
November 25, 2016 08:07 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 47 / 2016 ...
Zealand forhøjer aktiekapitalen som følge af udnyttelse af medarbejderwarrants
November 25, 2016 08:07 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Selskabsmeddelelse - Nr. 47 / 2016 ...
The U.S. FDA approves Soliqua(TM) 100/33 for the treatment of adults with type 2 diabetes
November 21, 2016 19:37 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 46 / 2016 ...
FDA i USA godkender Soliqua(TM) 100/33 til behandling af voksne med type 2-diabetes
November 21, 2016 19:37 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Selskabsmeddelelse - Nr. 46 / 2016 ...
Zealand increases its share capital as a consequence of exercise of employee warrants
November 17, 2016 03:26 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No. 45 / 2016 ...
Zealand forhøjer aktiekapitalen som følge af udnyttelse af medarbejderwarrants
November 17, 2016 03:26 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Selskabsmeddelelse - Nr. 45 / 2016 ...
Positiv udtalelse fra CHMP der anbefaler godkendelse af Suliqua(TM) (iGlarLixi) i Europa
November 11, 2016 07:44 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Selskabsmeddelelse - Nr. 44 / 2016 ...
CHMP issues positive opinion recommending Suliqua(TM) (iGlarLixi) for approval in the EU
November 11, 2016 07:44 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Company announcement - No....
Zealand præsenterer på tre internationale biotek/healthcare- investorkonferencer i november og december 2016
November 10, 2016 07:02 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Investornyheder - Nr. 8 / 2016 ...
Zealand presents at three international biotech/healthcare investor conferences in November and December 2016
November 10, 2016 07:02 ET
|
Zealand Pharma
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Investor News - No. 8 / 2016 Zealand...